Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gutsch

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular and Cellular Biology|March 1, 1994
Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latencyQ Zhang, D Gutsch, S Kenney
Lancet (London, England)|August 11, 1990
Ventricular arrhythmia in secondary syphilisP Becherer, D Gutsch, J Fischer
Journal of Virology|May 1, 1991
EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virusN S Sung, S Kenney, D Gutsch, et al.
Journal of Medical Virology|July 1, 1993
Detection of low level of human papilloma virus type 16 DNA sequences in cancer cell lines derived from two well-differentiated nasopharyngeal cancersE S Huang, D Gutsch, K W Tzung, et al.
Oncogene|July 12, 2011
The proto-oncogene Pim-1 is a target of miR-33aM Thomas, K Lange-Grünweller, U Weirauch, et al.
Nucleic Acids Research|July 11, 1993
Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1E B Quinlivan, E A Holley-Guthrie, M Norris, et al.
Molecular and Cellular Biology|January 1, 1992
The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cellsS C Kenney, E Holley-Guthrie, E B Quinlivan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular and Cellular Biology|March 1, 1994
Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latencyQ Zhang, D Gutsch, S Kenney
Lancet (London, England)|August 11, 1990
Ventricular arrhythmia in secondary syphilisP Becherer, D Gutsch, J Fischer
Journal of Virology|May 1, 1991
EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virusN S Sung, S Kenney, D Gutsch, et al.
Journal of Medical Virology|July 1, 1993
Detection of low level of human papilloma virus type 16 DNA sequences in cancer cell lines derived from two well-differentiated nasopharyngeal cancersE S Huang, D Gutsch, K W Tzung, et al.
Oncogene|July 12, 2011
The proto-oncogene Pim-1 is a target of miR-33aM Thomas, K Lange-Grünweller, U Weirauch, et al.
Nucleic Acids Research|July 11, 1993
Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1E B Quinlivan, E A Holley-Guthrie, M Norris, et al.
Molecular and Cellular Biology|January 1, 1992
The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cellsS C Kenney, E Holley-Guthrie, E B Quinlivan, et al.
Pageof 1